Ngai Hang Victor Chong insider trades: Clearside Biomedical (CLSD) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ngai reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | CLSD | ↑ Buy | 36,500 | $1.00 | $37K | Direct | Nov 4, 2024 (3d) |
| Jun 24, 2024 | CLSD | ↑ Buy | 23,500 | $1.06 | $25K | Direct | Jun 24, 2024 (0d) |
| Mar 20, 2024 | CLSD | ↑ Buy | 30,000 | $1.60 | $48K | Direct | Mar 20, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Ngai Hang Victor Chong's insider trades
Ngai Hang Victor Chong is Chief Medical Officer at Clearside Biomedical (CLSD). Since Mar 20, 2024, Ngai has reported 3 open-market purchases worth $109K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLSD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.